What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Christopher I. Li mostly deals with Breast cancer, Cancer, Internal medicine, Gynecology and Oncology.
His Breast cancer research is multidisciplinary, incorporating elements of Carcinoma and Cohort study.
His Cohort study research incorporates themes from Surgical oncology and Prospective cohort study.
His work carried out in the field of Cancer brings together such families of science as Odds ratio, Epidemiology and Retrospective cohort study.
The Epidemiology study combines topics in areas such as Pacific islanders, Incidence and Confidence interval.
His Oncology study incorporates themes from Survival analysis and Breast disease.
His most cited work include:
- Differences in breast cancer stage, treatment, and survival by race and ethnicity. (587 citations)
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status (549 citations)
- Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. (522 citations)
What are the main themes of his work throughout his whole career to date?
Christopher I. Li mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer and Gynecology.
Christopher I. Li is interested in Estrogen receptor, which is a field of Breast cancer.
His Estrogen receptor research is multidisciplinary, incorporating perspectives in Hormonal therapy and Breast feeding.
His Oncology research includes elements of Retrospective cohort study, Pathology, Ductal carcinoma, Proportional hazards model and Hormone therapy.
His Cancer study combines topics in areas such as Disease and Gerontology.
Christopher I. Li combines subjects such as Young adult, Menopause and Obstetrics with his study of Gynecology.
He most often published in these fields:
- Breast cancer (83.17%)
- Internal medicine (78.55%)
- Oncology (67.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (78.55%)
- Colorectal cancer (19.47%)
- Oncology (67.66%)
In recent papers he was focusing on the following fields of study:
Christopher I. Li mainly investigates Internal medicine, Colorectal cancer, Oncology, Cancer and Breast cancer.
His Colorectal cancer study integrates concerns from other disciplines, such as Mendelian randomization, Genome-wide association study, Epidemiology, Gastroenterology and Genotype.
The concepts of his Oncology study are interwoven with issues in Medical record, Young adult, Biomarker, Epigenetics and Risk factor.
Christopher I. Li interconnects Randomized controlled trial and Quality of life in the investigation of issues within Cancer.
His study on Estrogen receptor and Breast cancer screening is often connected to Surveillance, Epidemiology, and End Results as part of broader study in Breast cancer.
His study in Estrogen receptor is interdisciplinary in nature, drawing from both Diabetes mellitus and Metformin.
Between 2018 and 2021, his most popular works were:
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
- Novel Common Genetic Susceptibility Loci for Colorectal Cancer (57 citations)
- Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density (45 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Internal medicine, Colorectal cancer, Oncology, Cancer and Genome-wide association study.
His work on Breast cancer, Prospective cohort study and Cancer related distress as part of general Internal medicine study is frequently connected to Social support, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Christopher I. Li undertakes interdisciplinary study in the fields of Breast cancer and Genetic correlation through his research.
His work carried out in the field of Colorectal cancer brings together such families of science as Mendelian randomization, Quality of life and Case-control study.
His biological study spans a wide range of topics, including Young adult, Epidemiology, Family history and Cohort.
His studies deal with areas such as Odds ratio, Epigenetics and DNA methylation as well as Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
